The 12th Annual Pediatric Research Day: Innovative And Emerging Technologies In Pediatrics will be Friday, March 22, 2013, at the Sparrow Hospital Auditorium, Lansing, Michigan.
- Gayle Gordillo, MD, Associate Professor of Plastic Surgery; Vice Chair of Research, Department of Plastic Surgery, Ohio State University.
- Rangaramanujam Kannan, PhD, Professor of Ophthalmology, Wilmer Eye Institute, Center of Nanomedicine, Johns Hopkins School of Medicine.
The joint Michigan State University/Wayne State University Pediatric Research Day Committee invites and encourages submissions of abstracts for presentation at the 12th Annual Pediatric Research Day. Abstract submissions must involve child-health related research.
In addition to the poster session some individuals will be selected to give a short oral presentation and will be notified in advance. Trainee Research awards will be given for the best oral and poster presentations in several different categories. Undergraduate student, medical student, resident, fellow, masters graduate student, PhD graduate student, Post-doctoral fellow, faculty, staff, other (e.g., laboratory assistants, genetic counselors, nurses, etc), as well at MSU and WSU faculty are all encouraged to submit an abstract; however, MSU and WSU Faculty will not be eligible for awards.
DEADLINE FOR ABSTRACTS: Friday, February 15, 2013
Download the attached instructions, then submit abstract(s) as an e-mail attachment to Michelle Volker.
- 8:00–8:45: Registration/Breakfast/Poster set-up
- 8:45–9:00: Welcome
- 9:00–10:00: Rangaramanujam Kannan, PhD, Nanotechnology-based Targeted Therapies for Perinatal Brain Injury and Beyond
- 10:00–10:45: Oral Presentations (x 3)
- 10:45–12:00: Poster Session #1
- 12:00–12:45: Lunch
- 12:45-2:00: Poster Session #2
- 2:00–3:00: Gayle Gordillo, MD, From Strawberries to Blueberries: The Search for Better Treatment Options for Hemangiomas
- 3:00 – 3:45: Oral Presentations (x3)
- 3:45 – 4:00: Awards/Closing
Gayle Gordillo, MD, FACS, received her undergraduate degree in psychology from Stanford University. She graduated from The Ohio State University College of Medicine and did general surgery and plastic surgery residency training there. She joined the faculty at Ohio State University in August, 1999. Since joining the faculty, she has served briefly as the Director of the OSU Burn Unit and founded 2 multidisciplinary translational research outlets: 1) the Hemangioma and Vascular Malformation Clinic at Nationwide Children’s Hospital and 2) the Comprehensive Wound Center at the OSU Wexner Medical Center. Both sites currently conduct NIH sponsored clinical and translational research. Dr. Gordillo has transitioned from a K08 awardee to an independent investigator and currently holds an active R01 studying mechanisms that regulate the growth of endothelial cell tumors. She also serves as an ad hoc reviewer for the Bioengineering Technology and Surgical Sciences study section for the National Institutes of Health.
Rangaramanujam Kannan, PhD, is a professor and co-Director of the Center of Nanomedicine at the Wilmer Eye Institute at Johns Hopkins University School of Medicine, from August 2011. Before that, Professor Kannan was a faculty in the Department of Chemical Engineering and Materials Science at Wayne State University and Director of the Nanotechnology Lab at the NICHD Perinatology Research Branch, located at WSU. He obtained his Ph.D. in Chemical Engineering from California Institute of Technology, receiving the Unilever award for the best Ph.D. thesis in the country in the field of polymer science. After a year of postdoc at the University of Minnesota, and one year at 3M Corporate Research, he joined the faculty at WSU, where he won the NSF CAREER award. He has 7 patents and more than 75 refereed publications. He is also a co-founder and chief technology officer of Nanoscience Engineering Corporation, and is on the editorial board of the journal, Nanomedicine: Nanotechnology, Biology and Medicine. At Johns Hopkins, he leads an effort towards translational nanomedicine based on dendrimer-based targeted drug delivery systems for perinatal brain injury and other neurodegenerative diseases. His group has discovered the unique abilities of dendrimers to target neuoinflammation and is utilizing these for targeted therapy. They achieve this through synthesis, in vitro and in vivo characterization of custom-designed dendrimer-based multifunctional nanodevices for the treatment of neuroinflammation, cancer and other diseases.
Download registration flyer